Conclusion
Tadalafil and a combination of mirabegron and solifenacin improved the SRSs in three weeks. However, additional benefits can be achieved using tadalafil 10 mg. This may imply the single use of tadalafil 10 mg in overcoming SRSs is more considered than the combination therapy, particularly in patients with drug compliance problems. There is a need for further research on the effectiveness of single groups and combination groups with more varied types and doses of drugs, screening for more specific sample characteristics so that the results of the questionnaire conducted can be more homogeneous, and observations with a larger number of samples and a more extended study period to determine short-term and long-term effects and evaluation in therapy in this study.